Form 8-K - Current report:
SEC Accession No. 0001564590-15-005060
Filing Date
2015-06-15
Accepted
2015-06-12 17:50:59
Documents
1
Period of Report
2015-06-09
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 8-K cdtx-8k_20150609.htm 8-K 39260
  Complete submission text file 0001564590-15-005060.txt   40568
Mailing Address 6310 NANCY RIDGE DRIVE SUITE 101 SAN DIEGO CA 92121
Business Address 6310 NANCY RIDGE DRIVE SUITE 101 SAN DIEGO CA 92121 858-752-6170
Cidara Therapeutics, Inc. (Filer) CIK: 0001610618 (see all company filings)

EIN.: 461537286 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36912 | Film No.: 15929589
SIC: 2836 Biological Products, (No Diagnostic Substances)